The following statement was issued by Richard Fiesta, Executive Director of the Alliance for Retired Americans, regarding the Administration’s announcement of lower, negotiated prices for people with Medicare:
“The requirement that Medicare negotiate lower prices for prescription drugs continues to pay dividends for older Americans and taxpayers. Today’s announcement of lower drug prices for 15 high-priced drugs is a win for the more than 5 million seniors who take these drugs to treat asthma, diabetes, lung disease, and other serious conditions, and will soon pay less for their medications.
“The 4.4 million members of the Alliance are pleased that the Trump Administration has followed the law, negotiated these prices, and defended this law in court.
“We call on the President to work with Congress to increase the number of drugs subject to price negotiation and use this common sense approach to deliver even more savings for the American people.”
###
Contact: Lisa Cutler at [email protected]
The post Retirees Welcome Second Round of Lower-Priced Drugs Negotiated Under the Inflation Reduction Act appeared first on Retired Americans.